ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02019264
Brief Title: A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors (CAMELLIA-TIMI)

First Submitted : December 18, 2013
First Submitted that Met QC Criteria : December 18, 2013
First Posted : December 24, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2017
Last Update Posted : November 6, 2017